期刊文献+

高危子宫内膜癌术后辅助同步放化疗与单纯放疗的临床对比 被引量:12

Comparative Study of Concurrent Chemoradiotherapy with Simplex Radiotherapy after Radical Surgery for High-risk Endometrial Cancer
下载PDF
导出
摘要 目的对比研究顺铂联合五氟尿嘧啶(PF方案)同步放化疗与单纯放疗辅助治疗术后高危子宫内膜癌的毒性反应和复发,发现盆腔或远处转移病灶.方法选择2011年10月至2013年6月云南省肿瘤医院初治、接受规范分期手术,有高危因素的子宫内膜癌患者43例为研究对象,22例行单纯放射治疗,21例行术后辅助DDP+5-FU同步放化疗治疗,对比2组的毒性反应和复发率.结果同步放化疗组与单纯放疗组3极胃肠道反应率分别为61.90%和31.82%(P<0.05),差异有统计学意义;2组2级以上骨髓抑制率分别为66.67%和18.18%(P<0.01),差异有统计学意义;2组2级以上周围神经毒性反应率分别为33.33%和13.64%(P>0.05).同步放化疗组与单纯放疗组总体复发率分别为4.76%和27.27%(P<0.05),差异有统计学意义.结论同步放化疗3级胃肠道反应率增加,2级以上骨髓抑制率显著增加,周围神经毒性反应率不增加,毒性反应可以耐受,减少2 a总体复发率. Objective To compare the toxicities and recurrence rate with concomitant chemoradiotherapy(CRT) and radiotherapy(RT) alone after radical surgery for high-risk endometrial cancer. Methods A total of43 patients with high-risk endometrial cancer who received standard surgery treatment from Yunnan Cancer Hospital between Oct. 2011 to Jun. 2014 were selected in this study. CRT was given to 21 patients and RT was given to 22 patients. The toxic reactions and the recurrence rate were compared between two groups. Results In Concurrent chemotherapy and radiotherapy alone group, the incidence of Grade 3 gastrointestinal reaction was 61.90% and31.82% respectively, the difference was statistically significant(P 〈0.05); the incidence of Grade 2 marrow suppression was 66.67% and 18.18% respectively, the difference was significant(P 〈0.01); the incidence of Grade 2 neurotoxicity was 33.33% and 13.64%,respectively(P 〉0.05);the overall recurrence rate was 4.76%and 27.27%, respectively(P〈 0.05). Conclusion Compared with the simple radiotherapy, after the concurrent chemoradiotherapy, the incidence of Grade 3 gastrointestinal reaction may increase, the incidence of Grade 2 Bone marrow suppression may also increase significantly,while the incidence of peripheral neurotoxicity may not increase,the toxicity is acceptable, and the 2-year recurrence rate may decrease.
出处 《昆明医科大学学报》 CAS 2016年第1期81-84,共4页 Journal of Kunming Medical University
基金 云南省应用基础研究基金资助项目(2011FZ130)
关键词 子宫内膜癌 同步放化疗 放射治疗 Endometrial cancer Concurrent chemoradiotherapy Radiotherapy
  • 相关文献

参考文献19

  • 1ELSHAIKH M A, VANCE S, SURI J S, et al. Improved s- urvival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma [J]. Int J Radiat Oncol Biol Phys,2014,88(2):351--356. 被引量:1
  • 2WETHINGTON S L,BARRENA MEDEL N I,WRIGHT J D, et al. Prognostic significance and treatment implications of ad positive peritoneal cytologyin endometrial :Unraveling a mystery [J]. Gynecol Oncol, 2009,115( 1 ) :18--25. 被引量:1
  • 3GADDUCCI A, COSIO S, LANDONI F, et al. Adjuvant tr- eatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study) [ J ]. Gynecol Oncol, 2014, 134( 1 ):29-- 35. 被引量:1
  • 4BOGANI G, CROMI A, SERATI M, et al. Chemotherapy r- educes para-aortic node recurrences in endometrial cancer with positive pelvic and unknown para-aortic nodes [J].Int J Gynecol Cancer, 2015,25 (2):263 -- 268. 被引量:1
  • 5KLOPP A H ,JHINGRAN A,RAMONDETrA L,et al. No- de-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation [ J ]. Gynecol Oncol, 2009, 115 ( 1 ) : 6-- 11. 被引量:1
  • 6LANDRUM L M,NUGENT E K,ZUNA R E,et al. Phase I1 trim of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors [J]. Gynecol Oncol, 2014,132(1 ):50--54. 被引量:1
  • 7LEE J H,LEE H C,KIM S H,et al. Postoperative radiotherapy alone versus chemoradiotherapy in stage I-II endometrial carcinoma: an investigational and propensity score matching analysis [ J ]. Cancer Res Treat, 2015,47 (2):298--305. 被引量:1
  • 8LEE J Y,KIM K,LEE T S, et al. Controversies in the management of endometrial cancer: a survey of the korean gynecologic oncology group [J]. J Gynecol Oncol, 2015,26(4):277--283. 被引量:1
  • 9SIGNORELLI M,LISSONI A A,DE PONTI E,et al. Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer[J ]. J Gyneeol Oncol,2015,26(4):284--292. 被引量:1
  • 10CHO H,NAM B H, KIM S M, et al. A phase 2 trial of radiation therapy with concurrent paclitaxel chemotherapy after surgery in patients with high-risk endometrial cancer: a korean gynecologic oncologic group study [J]. Int J Radiat Oncol Biol Phys,2014,90( 1 ):140-- 146. 被引量:1

二级参考文献24

  • 1Rosato V,Zucchetto A,Bosetti C,et al.Metabolic syndrome and endometrial cancer risk[J].Ann Oncol,2011,22(4):884-889. 被引量:1
  • 2Plati E,Kouskouni E,Malamitsi-Puchner A,et al.Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation[J].Fetil Steril,2010,94(4):1451. 被引量:1
  • 3McTiernan A,Irwin M,Vongruenigen V.Weight,physical activity,diet,and prognosis in breast and gynecologic cancers[J].J Clin Oncol,2010,28(26):4074-4080. 被引量:1
  • 4Friedenreich CM,Biel RK,Lau DC,et al.Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer[J].Cancer Epidemiol Biomarkers Prev,2011,20(11):2384-2395. 被引量:1
  • 5Mulholland DJ,Kobayashi N,Ruscetti M,et al.Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells[J].Cancer Research,2012,72(7):1878-1889. 被引量:1
  • 6Hotamisligil GS,Shargill NS,Spiegelman BM.Adipose expression of tumor necrosis factor-alpha:direct role in obesitylinked insulin resistance[J].Science,1993,259(5091):87-91. 被引量:1
  • 7Jaiyeoba O,Lazenby C,Soper DE.Recommendations and rationale for the treatment of pelvic inflammatory disease[J].Expert Rev Anti Infect Ther,2011,9(1):61-67. 被引量:1
  • 8Kajo K,VallováM,BiróC,et al.Molecular pathology of endometrial carcinoma-a review[J].CeskPatol,2015,51(2):65-73. 被引量:1
  • 9Frey MK,Lin JF,Stewart LE,et al.Comparison of two minimally invasive approaches to endometrial cancer staging:a single-surgeon experience[J].J Reprod Med,2015,60(3-4):127-134. 被引量:1
  • 10Ruiz-Morales JM,Dorantes-Heredia R,Arrieta O,et al.Neutrophil gelatinase-associated lipocalin(NGAL)and matrix metalloproteinase-9(MMP-9)prognostic value in lung adenocarcinoma[J].TumourBiol,2015,36(5):3601-3610. 被引量:1

共引文献17

同被引文献93

引证文献12

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部